Clade Therapeutics
Latest round
- Series A
Last raised
- Aug 2021
Total raised
- $46M
Investors
- 4
About Clade Therapeutics
Founded in 2020 and based in Massachusetts, US, Clade Therapeutics, Inc. operates as a clinical drug development company that develops drugs for patients with cancer diseases. The company was founded by its CEO, Chad Cowan, CBO Jim Glasheen, Deepta Bhattacharya, and Gustavo Mostoslavsky., a portfolio company of Avidity Partners, Venrock Healthcare Capital Partners, and DAFNA Capital Management, acquired Clade Therapeutics, Inc. from Bristol-Myers Squibb Company, Emerson Collective, LifeSci Partners, and Syncona Limited for USD 35 million. The company will receive an additional USD 10 million upon reaching certain milestones. Clade develops cell medicines, mainly iPSC-derived cells, to treat cancer and autoimmune diseases. The company offers an aß iT platform, which is an iPSC-derived cell therapy that provides iPSC-derived aß T cells. The company uses induced pluripotent stem cells (iPSCs) to create adult human T cells, Treg cells, and B cells. These cells can be used to target and destroy cancer cells or suppress autoimmune responses. The firm’s pipeline program includes CAR-T (Chimeric Antigen Receptor T-cell) therapies for treating cancer, which have a combination of iPSC-derived CD8+ and CD4+ aß CAR-T cells.
Who invested in Clade Therapeutics
4 investors across 1 round
See all investors in Clade Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Aug 11, 2021
Amount
$46M
Investors
Questions about Clade Therapeutics
Who invested in Clade Therapeutics?
Clade Therapeutics has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Clade Therapeutics raised?
Clade Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Clade Therapeutics last raise money?
Clade Therapeutics's most recent round on record is a Series A, in Aug 2021.
What does Clade Therapeutics do?
Founded in 2020 and based in Massachusetts, US, Clade Therapeutics, Inc.
Where is Clade Therapeutics headquartered?
Clade Therapeutics is headquartered in Boston, US.
Which VCs invest in companies like Clade Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Clade Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Clade Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.